This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of DexCom Inc. slipped 9.1% to $70.72 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.7% to 5,614.56 and Dow Jones Industrial Average falling 2.1% to 41,911.71.
This was the stock's sixth consecutive day of losses.
DexCom Inc. closed 50.2% short of its 52-week high of $142.00, which the company reached on March 26th.
The stock underperformed when compared to some of its competitors, as Abbott Laboratories rose 0.2% to $137.36, Insulet Corp. fell 5.9% to $237.06.
Trading volume totaled 8.3 million, compared to the 50-day average of 3.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 10, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。